PHOSPHOCYSTEAMINE IN THE TREATMENT OF CYSTINOSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MADANI ABAS; HADJIZADEH N.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pediatrics Year:2003 | Volume:13 | Issue:1 Page(s): 42-46

Download Full-Text

Persian Verion

View:

1,287

Download:

Cites:

Information Journal Paper

Title

PHOSPHOCYSTEAMINE IN THE TREATMENT OF CYSTINOSIS

Author(s)

MADANI ABAS | HADJIZADEH N. | Issue Writer Certificate

Keywords

CYSTINOSISQ4

FANCONI SYNDROMEQ4

PHOSPJCYSTEAMINEQ4

NEPHROPATHYQ4

KIDNEY CLEARANCEQ4

Abstract

CYSTINOSIS is a relatively rare recessive autosomal inherited metabolic disease. In this metabolic anomaly free cystin is accumulated in the cell lysozymes of the different body tissues. The nephritic form of the disease begins in infancy and leads to FANCONI SYNDROME with polyuria, polydisia, metabolic acidosis, phosphaturia and Vitamin D-resistent rickets. If not treated, it can end in chronic kidney insufficiency. In the beginning of the disease phosphocysteamine can prevent the accumulation of cystin in the lysozymes and can hinder the progress of the disease.In our study we treated 15 CYSTINOSIS patients (7 girls, 8 boys) with phosphocystamine. The mean age at beginning of the symptoms was 8.4 months. Unfortunately, the disease was diagnosed and treatment started at a mean age of 3.58 years. Therefore, all patients had their kidney complications at the time the treatment with phosphocysteamind began. Anyhow, creatinine clearance increased after treatment in 12 patients. There was a significant relation between the time of beginning of the treatment and patients condition after treatment, i.e. the earlier the treatment began, the better was the function of the kidneys after treatment with phosphocysteamin.

Cites

No record.

References

No record.

Cite

APA: Copy

MADANI, ABAS, & HADJIZADEH, N.. (2003). PHOSPHOCYSTEAMINE IN THE TREATMENT OF CYSTINOSIS. IRANIAN JOURNAL OF PEDIATRICS, 13(1), 42-46. SID. https://sid.ir/paper/76083/en

Vancouver: Copy

MADANI ABAS, HADJIZADEH N.. PHOSPHOCYSTEAMINE IN THE TREATMENT OF CYSTINOSIS. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2003;13(1):42-46. Available from: https://sid.ir/paper/76083/en

IEEE: Copy

ABAS MADANI, and N. HADJIZADEH, “PHOSPHOCYSTEAMINE IN THE TREATMENT OF CYSTINOSIS,” IRANIAN JOURNAL OF PEDIATRICS, vol. 13, no. 1, pp. 42–46, 2003, [Online]. Available: https://sid.ir/paper/76083/en

Related Journal Papers